• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Kahn Swick & Foti

Kahn Swick & Foti represents investors in securities fraud class actions, as well as shareholders and consumers harmed by corporate wrongdoing.

  • About Us
    • About Our Firm
    • Institutional Investor Services
    • KSF in the Community
    • Careers at KSF
    • Contact Us
  • Attorneys
  • Practice Areas
    • Securities Class Action Litigation
    • Corporate Governance And Derivative Litigation
    • Consumer Protection Litigation
    • Shareholder Mergers and Acquisitions Class Action Litigation
    • Antitrust Litigation
  • Current Cases
  • KSF News
  • Client Login
  • Asset Recovery Services
  • Contact KSF

Lead Plaintiff Defeats Motion to Dismiss in Orexigen Therapeutics Litigation

Home»News»Lead Plaintiff Defeats Motion to Dismiss in Orexigen Therapeutics Litigation

On September 23, 2019, the United States District Court for the Southern District of California entered an order denying in large part defendants’ motion to dismiss. The Hon. Janis L. Sammartino found that Lead Plaintiff’s allegations gave rise to a strong inference of scienter (i) on behalf of Preston Klassen, Michael A. Narachi, and Joseph P. Hagan with respect to their materially misleading statements and omissions on May 8, 2015 and (ii) on behalf of Defendants Narachi and Klassen with respect to their materially misleading statements and omissions on March 3, 2015. This successful result was obtained after KSF prevailed in the Ninth Circuit Court of Appeals and in the United States Supreme Court.

Filed Under: News

Previous Post: « Lead Plaintiff Defeats Motion to Dismiss in Part in In Re Health Insurance Innovations

Reader Interactions

Primary Sidebar

Current Cases

Fiat Chrysler Automobiles N.V. (NYSE: FCAU)

Merit Medical Systems, Inc. (NasdaqGS: MMSI)

Prudential Financial, Inc. (NYSE: PRU)

Baxter International Inc. (NYSE: BAX)

The We Company, Inc. (“WeWork”).

Bellicum Pharmaceuticals, Inc. (NasdaqGM: BLCM) Investigation

see more»
 

Join Our Mailing List

To receive news of interest to shareholders and consumers and learn about potential new cases, you may join our mailing list by entering your email below.

Terms and Conditions | Privacy Notice

© 2006-2019 Copyright. All rights reserved Kahn Swick & Foti LLC · Louisiana · New York — Kahn Swick & Foti LLP · California